Venus Remedies Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.136x

Venus Remedies Limited cash flow conversion efficiency. Based on the latest financial reports, Venus Remedies Limited (VENUSREM) has a cash flow conversion efficiency ratio of 0.136x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs811.10 Million ≈ $8.77 Million USD) by net assets (Rs5.94 Billion ≈ $64.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Venus Remedies Limited (2006–2025)

Cash flow conversion efficiency of Venus Remedies Limited from 2006 to 2025. This chart illustrates how Venus Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Venus Remedies Limited for real-time trading data and today's change.

Venus Remedies Limited Cash Flow Conversion Ratio Explained

Venus Remedies Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Venus Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Venus Remedies Limited ranked by their cash flow conversion efficiency. Also see VENUSREM company net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
AVY Precision Technology TWO:5392	-0.008x
QuantaSing Group Limited American Depositary Shares NASDAQ:QSG	0.061x
Eaton Vance Municipal Income Term Closed Fund NYSE:ETX	0.015x
Alfas Solar Enerji Sanayi ve Ticaret A.S. IS:ALFAS	0.291x
Ledesma SAAI BA:LEDE	0.123x
Kross Ltd NSE:KROSS	0.010x
Digital Currency X Technology Inc. NASDAQ:DCX	-0.005x
Camlin Fine Sciences Limited NSE:CAMLINFINE	0.078x

Annual Cash Flow Conversion Efficiency for Venus Remedies Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Venus Remedies Limited from 2006 to 2025. Review Venus Remedies Limited free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs5.61 Billion ≈ $60.66 Million	Rs909.20 Million ≈ $9.83 Million	0.162x	+111.94%
2024-03-31	Rs4.88 Billion ≈ $52.73 Million	Rs372.85 Million ≈ $4.03 Million	0.076x	-3.87%
2023-03-31	Rs4.60 Billion ≈ $49.78 Million	Rs366.20 Million ≈ $3.96 Million	0.080x	-14.55%
2022-03-31	Rs4.40 Billion ≈ $47.63 Million	Rs410.01 Million ≈ $4.43 Million	0.093x	-71.90%
2021-03-31	Rs4.00 Billion ≈ $43.29 Million	Rs1.33 Billion ≈ $14.34 Million	0.331x	+39.12%
2020-03-31	Rs3.23 Billion ≈ $34.97 Million	Rs770.10 Million ≈ $8.33 Million	0.238x	+74.71%
2019-03-31	Rs3.33 Billion ≈ $35.96 Million	Rs453.27 Million ≈ $4.90 Million	0.136x	-4.09%
2018-03-31	Rs3.62 Billion ≈ $39.14 Million	Rs514.36 Million ≈ $5.56 Million	0.142x	-35.64%
2017-03-31	Rs4.52 Billion ≈ $48.84 Million	Rs997.24 Million ≈ $10.78 Million	0.221x	+106.13%
2016-03-31	Rs4.38 Billion ≈ $47.33 Million	Rs468.81 Million ≈ $5.07 Million	0.107x	-27.85%
2015-03-31	Rs4.57 Billion ≈ $49.39 Million	Rs678.05 Million ≈ $7.33 Million	0.148x	+30.18%
2014-03-31	Rs4.62 Billion ≈ $49.92 Million	Rs526.46 Million ≈ $5.69 Million	0.114x	-17.09%
2013-03-31	Rs3.79 Billion ≈ $41.00 Million	Rs521.50 Million ≈ $5.64 Million	0.138x	+1.44%
2012-03-31	Rs3.07 Billion ≈ $33.23 Million	Rs416.70 Million ≈ $4.51 Million	0.136x	-13.98%
2011-03-31	Rs2.37 Billion ≈ $25.62 Million	Rs373.47 Million ≈ $4.04 Million	0.158x	-14.83%
2010-03-31	Rs1.71 Billion ≈ $18.51 Million	Rs316.83 Million ≈ $3.43 Million	0.185x	+35.37%
2009-03-31	Rs1.39 Billion ≈ $14.99 Million	Rs189.50 Million ≈ $2.05 Million	0.137x	-36.02%
2008-03-31	Rs889.86 Million ≈ $9.62 Million	Rs190.17 Million ≈ $2.06 Million	0.214x	-50.89%
2007-03-31	Rs551.31 Million ≈ $5.96 Million	Rs239.88 Million ≈ $2.59 Million	0.435x	+58.20%
2006-03-31	Rs318.96 Million ≈ $3.45 Million	Rs87.73 Million ≈ $948.76K	0.275x	--

About Venus Remedies Limited

NSE:VENUSREM India Drug Manufacturers - Specialty & Generic

Market Cap

$190.12 Million

Rs17.58 Billion INR

Market Cap Rank

#16521 Global

#848 in India

Share Price

Rs1315.20

Change (1 day)

+1.13%

52-Week Range

Rs441.75 - Rs1947.00

All Time High

Rs1947.00